ibrexafungerp
Showing 1 - 6 of 6
Fungal Disease Trial in Nottingham (Ibrexafungerp)
Recruiting
- Fungal Disease
- Ibrexafungerp
-
Nottingham, United KingdomQuotient Sciences Limited
Dec 20, 2022
Vulvovaginal Candidiasis Trial in United States (Ibrexafungerp)
Recruiting
- Vulvovaginal Candidiasis
- Ibrexafungerp
-
Phoenix, Arizona
- +17 more
Aug 16, 2022
Invasive Candidiasis, Mucocutaneous Candidiasis, Coccidioidomycosis Trial in Worldwide (Ibrexafungerp)
Active, not recruiting
- Invasive Candidiasis
- +9 more
- Ibrexafungerp
-
Birmingham, Alabama
- +36 more
Jan 25, 2023
Recurrent Vulvovaginal Candidiasis Trial in United States (Fluconazole Tablet, IBREXAFUNGERP, Placebo oral tablet)
Completed
- Recurrent Vulvovaginal Candidiasis
- Fluconazole Tablet
- +2 more
-
Phoenix, Arizona
- +24 more
Apr 15, 2022
Candida Vulvovaginitis Trial in United States (Ibrexafungerp, Placebo)
Completed
- Candida Vulvovaginitis
- Ibrexafungerp
- Placebo
-
Birmingham, Alabama
- +24 more
Aug 11, 2021
Candida Vulvovaginitis Trial in Bulgaria, United States (Ibrexafungerp, Placebo)
Completed
- Candida Vulvovaginitis
- Ibrexafungerp
- Placebo
-
Mesa, Arizona
- +40 more
Aug 11, 2021